205TiP ATRACTIB: A phase II trial of first-line (1L) atezolizumab (A) in combination with paclitaxel (P) and bevacizumab (B) in metastatic triple-negative breast cancer (mTNBC)
| Autor: | Cortés Salgado, A., Perez Garcia, J.M., Cortez Castedo, S.P., Gion Cortes, M., Morales Murillo, S., Blancas López-Barajas, I., Blanch, S., Calvo Plaza, I., Diaz Fernandez, N., Marmé, F., Martinez Bueno, A., Taberner Bonastre, M.T., De Laurentiis, M., Ruiz Borrego, M., Schmid, P., Guarneri, V., Gligorov, J., Sampayo-Cordero, M., Llombart Cussac, A., Cortés, J. |
|---|---|
| Zdroj: | In Annals of Oncology May 2022 33 Supplement 3:S221-S221 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|